Ratnakar Securities Pvt. Ltd.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE901.05-23.8 (-2.57 %)

PREV CLOSE ( ) 924.85

OPEN PRICE ( ) 937.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7814

TODAY'S LOW / HIGH ( )870.00 937.80

52 WK LOW / HIGH ( ) 6501249

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-06 1987

Management Info

Daulat N Medhora - Chairman Fredun N Medhora - Managing Director

Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (W),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE

NEWS

22Mar Allotment of Convertible warrants
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..

22Mar Allotment of Equity Shares
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..

12Feb Fredun Pharmaceuticals gets orders wor
Fredun Pharmaceuticals has received large orders from Southeast Asian (S..

12Feb Fredun Pharmaceuticals informs about p
Fredun Pharmaceuticals has informed that it enclosed press release title..

19Jan Fredun Pharmaceuticals informs about v
Fredun Pharmaceuticals has informed that it enclosed the Voting Results..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	42.2100000000001	108.07
Gross Profit	57.6300000000001	175.09
Operating Profit	105.15	296
Net Sales	870.08	2764.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2377.00 (6.44%)	M.Cap ( in Cr)29930.39
Alkem Laboratories (BSE) 4899.45 (2.36%)	M.Cap ( in Cr)58580.27
Astrazeneca Pharma I (BSE) 5424.45 (1.70%)	M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE) 6349.95 (0.98%)	M.Cap ( in Cr)105928.76
Torrent Pharma (BSE) 2732.60 (2.20%)	M.Cap ( in Cr)92483.60

Shareholding Pattern

	NON-INSTITUTION	49.28%
	PROMOTERS	49.13%
	FI/BANKS/INSURANCE	1.6%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

FREDUN PHARMACEUTICALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES